304 related articles for article (PubMed ID: 9619788)
1. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders.
Maa YF; Nguyen PA; Andya JD; Dasovich N; Sweeney TD; Shire SJ; Hsu CC
Pharm Res; 1998 May; 15(5):768-75. PubMed ID: 9619788
[TBL] [Abstract][Full Text] [Related]
2. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
3. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.
Andya JD; Maa YF; Costantino HR; Nguyen PA; Dasovich N; Sweeney TD; Hsu CC; Shire SJ
Pharm Res; 1999 Mar; 16(3):350-8. PubMed ID: 10213364
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of IgG1 in spray-dried powders for inhalation.
Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
[TBL] [Abstract][Full Text] [Related]
5. Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.
Shetty N; Zeng L; Mangal S; Nie H; Rowles MR; Guo R; Han Y; Park JH; Zhou QT
Pharm Res; 2018 Jan; 35(1):7. PubMed ID: 29294198
[TBL] [Abstract][Full Text] [Related]
6. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
[TBL] [Abstract][Full Text] [Related]
7. Physical stability of salmon calcitonin spray-dried powders for inhalation.
Chan HK; Clark AR; Feeley JC; Kuo MC; Lehrman SR; Pikal-Cleland K; Miller DP; Vehring R; Lechuga-Ballesteros D
J Pharm Sci; 2004 Mar; 93(3):792-804. PubMed ID: 14762916
[TBL] [Abstract][Full Text] [Related]
8. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
Yu J; Romeo MC; Cavallaro AA; Chan HK
Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
[TBL] [Abstract][Full Text] [Related]
10. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
11. Spray-drying performance of a bench-top spray dryer for protein aerosol powder preparation.
Maa YF; Nguyen PA; Sit K; Hsu CC
Biotechnol Bioeng; 1998 Nov; 60(3):301-9. PubMed ID: 10099432
[TBL] [Abstract][Full Text] [Related]
12. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.
Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW
Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500
[TBL] [Abstract][Full Text] [Related]
13. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
Arte KS; Tower CW; Mutukuri TT; Chen Y; Patel SM; Munson EJ; Tony Zhou Q
Int J Pharm; 2024 Jan; 650():123698. PubMed ID: 38081559
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
15. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
16. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
[TBL] [Abstract][Full Text] [Related]
17. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
Momin MAM; Tucker IG; Das SC
Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
[TBL] [Abstract][Full Text] [Related]
18. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
[TBL] [Abstract][Full Text] [Related]
19. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
20. Co-spray dried hydrophobic drug formulations with crystalline lactose for inhalation aerosol delivery.
Ke WR; Kwok PCL; Khanal D; Chang RYK; Chan HK
Int J Pharm; 2021 Jun; 602():120608. PubMed ID: 33862136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
